# Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin

Study · id `cardio:ct-nct01596504` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01596504](<https://clinicaltrials.gov/study/NCT01596504>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01596504

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.

## Technical summary

Registry record NCT01596504. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-07 (actual). Results posted on 2016-10-14.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 142 participants (enrolled count; ClinicalTrials.gov record NCT01596504, source copy `cardio:ctgov-nct01596504-2016-10-14`, retrieved 2026-10-26)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT01596504, source copy `cardio:ctgov-nct01596504-2016-10-14`, retrieved 2026-10-26)
- Primary completion: 2013-07 (actual) (ClinicalTrials.gov record NCT01596504, source copy `cardio:ctgov-nct01596504-2016-10-14`, retrieved 2026-10-26)
- Completion: 2013-07 (actual) (ClinicalTrials.gov record NCT01596504, source copy `cardio:ctgov-nct01596504-2016-10-14`, retrieved 2026-10-26)
- Results first posted: 2016-10-14 (ClinicalTrials.gov record NCT01596504, source copy `cardio:ctgov-nct01596504-2016-10-14`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT01596504, source copy `cardio:ctgov-nct01596504-2016-10-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01596504-2016-10-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Lixisenatide (AVE0010)
- Intervention (Drug): Liraglutide
- Intervention (Drug): Insulin Glargine
- Intervention (Drug): Metformin
- Lead sponsor: Sanofi
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Sanofi (`cardio:org-sanofi`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial (`cardio:pubmed-25887358`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f911417e7635f0ec1b89938a3172500e809200f85138a4101ad0cabfcb909040
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
